Advertisement

More articles from Erratum

You have access
Correction to “Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity”
Journal of Pharmacology and Experimental Therapeutics April 2022, 381 (1) 67; DOI: https://doi.org/10.1124/jpet.121.000821err
You have access
Correction to “A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor ɣ with Excellent Effect on Insulin Resistance and Type 2 Diabetes”
Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 90-91; DOI: https://doi.org/10.1124/jpet.115.223107err
You have access
Correction to “Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II – Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertensin”
Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 322; DOI: https://doi.org/10.1124/jpet.121.000525err
You have access
Correction to “Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia”
Journal of Pharmacology and Experimental Therapeutics August 2021, 378 (2) 69; DOI: https://doi.org/10.1124/jpet.120.000166err
You have access
Correction to “Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome”
Journal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 368; DOI: https://doi.org/10.1124/jpet.119.262238err
You have access
Correction to “Glutathione S-Transferase P Influences Redox Homeostasis and Response to Drugs that Induce the Unfolded Protein Response in Zebrafish”
Journal of Pharmacology and Experimental Therapeutics April 2021, 377 (1) 199; DOI: https://doi.org/10.1124/jpet.120.000417err
You have access
Correction to “A Novel Mitochondrial Complex of Aldosterone Synthase, Steroidogenic Acute Regulatory Protein, and Tom22 Synthesizes Aldosterone in the Rat Heart”
Journal of Pharmacology and Experimental Therapeutics April 2021, 377 (1) 200; DOI: https://doi.org/10.1124/jpet.120.000365err
You have access
Correction to “Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury”
Journal of Pharmacology and Experimental Therapeutics March 2021, 376 (3) 463; DOI: https://doi.org/10.1124/jpet.120.000212err
You have access
Correction to “Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor”
Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 147; DOI: https://doi.org/10.1124/jpet.119.261065err
You have access
Correction to “Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Epigenetic Regulator Enhancer of Zeste Homolog 2”
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 238; DOI: https://doi.org/10.1124/jpet.119.263491err

Pages